483
Kevin B. Kim, Clinical InvestigatorFDA 483 - Kevin B. Kim, Clinical Investigator - October 16, 2013
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Kevin B. Kim, Clinical Investigator in Houston, TX, revealed significant deficiencies in clinical trial conduct. The observations included failures to obtain proper informed consent, deviations from the investigational plan, and inadequate investigational drug disposition records. These issues indicate a lack of adherence to regulatory requirements for human subject protection and clinical study management.
Open in Dashboard
ID · 58179df4-691f-4861-9d9b-8b7f89e06e3f